Old Web
English
Sign In
Acemap
>
Paper
>
Preclinical Evaluation of a Newcastle Disease Virus-Vectored Intranasal SARS-CoV-2 Vaccine
Preclinical Evaluation of a Newcastle Disease Virus-Vectored Intranasal SARS-CoV-2 Vaccine
2021
Manolo Fernández-Díaz
Katherine Calderón
Aldo Rojas-Neyra
Vikram N. Vakharia
Ricardo Choque Guevara
Ángela Montalván
Astrid Poma-Acevedo
Dora Rios-Matos
Andres Agurto-Arteaga
Maria De Grecia Cauti-Mendoza
Norma Perez-Martinez
Gisela Isasi-Rivas
Luis Tataje-Lavanda
Yacory Sernaque-Aguilar
Freddy Ygnacio-Aguirre
Manuel Criollo Orozco
Edison Huaccachi-Gonzalez
Elmer Delgado-Ccancce
Doris Villanueva-Pérez
Ricardo Montesinos-Millan
Kristel Gutierrez-Manchay
Katherine Pauyac-Antezana
Ingrid Ramirez-Ortiz
Stefany Quiñones-García
Yudith Cauna Orocollo
Katherine Vallejos-Sánchez
Angela Rios-Angulo
Dennis Nunez Fernandez
Mario I. Salguedo-Bohorquez
Julio Ticona
Manolo Fernández-Sánchez
Eliana Icochea
Luis Guevara-Sarmiento
Mirko Zimic
Keywords:
Virus
Newcastle disease
severe acute respiratory syndrome coronavirus 2
Virology
Nasal administration
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
16
References
0
Citations
NaN
KQI
[]